Obstructive sleep apnea severity, circulating biomarkers, and cancer risk
- PMID: 38648119
- PMCID: PMC11367715
- DOI: 10.5664/jcsm.11170
Obstructive sleep apnea severity, circulating biomarkers, and cancer risk
Abstract
Study objectives: To determine whether obstructive sleep apnea (OSA) severity and/or biomarkers of inflammation/angiogenesis are associated with incident cancer in this clinical cohort.
Methods: Consenting adult patients at the University of British Columbia Hospital between 2003 and 2014 completed a questionnaire about their medical history and sleep habits prior to undergoing a polysomnogram. Blood samples were collected the morning after polysomnography and processed for biomarkers of inflammation and angiogenesis. The clinical, polysomnography, and biomarker data were linked to the British Columbia Cancer Registry to ascertain incident cancer diagnoses. Cox proportional hazard regression was used to assess the association between OSA severity and biomarker concentrations with cancer risk.
Results: A total of 1,990 patients were included in the analysis with a mean follow-up time of 12.8 years; 181 of them (9.1%) developed cancer after polysomnography. OSA severity was significantly associated with cancer risk after controlling for relevant covariates (hazard ratio = 1.08 per 10 events/h apnea-hypopnea index increase, confidence interval = 1.02-1.15, P = .015). In an exploratory analysis, 2 biomarkers were significantly associated with an increased cancer risk after controlling for relevant covariates (hazard ratio per interquartile range pg/mL increase of endostatin = 1.45, confidence interval = 1.12-1.87, P = .01 and hazard ratio for interquartile range pg/mL increase of vascular cell adhesion molecule-1 = 1.48, confidence interval = 1.04-2.11, P = .03, respectively).
Conclusions: OSA severity was an independent risk factor for cancer. Furthermore, 2 circulating markers were significantly associated with cancer risk. If these preliminary findings can be reproduced in other cohorts, biomarkers could potentially be used to prognosticate patients with OSA with respect to cancer risk.
Citation: Hirsch Allen AJ, Kendzerska T, Bhatti P, et al. Obstructive sleep apnea severity, circulating biomarkers, and cancer risk. J Clin Sleep Med. 2024;20(9):1415-1422.
Keywords: apnea-hypopnea index; cancer; obstructive sleep apnea; polysomnography.
© 2024 American Academy of Sleep Medicine.
Conflict of interest statement
All the authors of this this manuscript have seen and approved the submission of this manuscript. Work for this manuscript was performed at the University of British Columbia. This study was supported by a VCHRI Investigator Award (Dr. Rachel Jen), a CIHR Team Grant, BC Lung Association Operating Grant, and a MITACS award. The sponsor had no role in the design of the study, the collection and analysis of the data, or the preparation of the manuscript. The abstract was previously published and presented at ATS 2023 in Washington, DC. The authors report no conflicts of interest.
Similar articles
-
Comparison of WatchPAT to polysomnography measurement of apnea-hypopnea index and obstructive sleep apnea severity in adolescents with overweight and obesity.J Clin Sleep Med. 2025 Apr 1;21(4):695-702. doi: 10.5664/jcsm.11530. J Clin Sleep Med. 2025. PMID: 39745453
-
Combining a wireless radar sleep monitoring device with deep machine learning techniques to assess obstructive sleep apnea severity.J Clin Sleep Med. 2024 Aug 1;20(8):1267-1277. doi: 10.5664/jcsm.11136. J Clin Sleep Med. 2024. PMID: 38546033 Free PMC article.
-
Ethnic/racial and sex disparities in obstructive sleep apnea among adolescents in southern California.J Clin Sleep Med. 2024 Oct 1;20(10):1637-1645. doi: 10.5664/jcsm.11238. J Clin Sleep Med. 2024. PMID: 38913342
-
Serum inflammatory markers in obstructive sleep apnea: a meta-analysis.J Clin Sleep Med. 2013 Oct 15;9(10):1003-12. doi: 10.5664/jcsm.3070. J Clin Sleep Med. 2013. PMID: 24127144 Free PMC article.
-
Association between obstructive sleep apnea and gastroesophageal reflux disease: A systematic review and meta-analysis.J Gastroenterol Hepatol. 2023 Aug;38(8):1244-1251. doi: 10.1111/jgh.16245. Epub 2023 Jun 10. J Gastroenterol Hepatol. 2023. PMID: 37300443
Cited by
-
Exploring the pharmacological mechanisms for alleviating OSA: Adenosine A2A receptor downregulation of the PI3K/Akt/HIF‑1 pathway (Review).Biomed Rep. 2024 Nov 28;22(2):21. doi: 10.3892/br.2024.1899. eCollection 2025 Feb. Biomed Rep. 2024. PMID: 39720297 Free PMC article. Review.
-
Mapping the comorbidome: A novel analysis of the associations between obstructive sleep apnea and its comorbidities in Colombia.Sci Prog. 2025 Apr-Jun;108(2):368504251335196. doi: 10.1177/00368504251335196. Epub 2025 Apr 22. Sci Prog. 2025. PMID: 40261326 Free PMC article.
-
Does the severity of obstructive sleep apnea increase the risk of cancer? Clues in apnea-hypopnea index and biomarkers.J Clin Sleep Med. 2024 Sep 1;20(9):1403-1404. doi: 10.5664/jcsm.11270. J Clin Sleep Med. 2024. PMID: 38958054 No abstract available.
References
-
- Ip M , Chung KF , Chan KN , Lam SP , Lee K . Previously unrecognized obstructive sleep apnea in Chinese subjects with essential hypertension . Lung. 1999. ; 177 ( 6 ): 391 – 400 . - PubMed
-
- Young T , Palta M , Dempsey J , et al . The occurrence of sleep-disordered breathing among middle-aged adults . N Engl J Med. 1993. ; 328 ( 17 ): 1230 – 1235 . - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical